Production of new anthracycline antibiotic betaclamycin B by microbial conversion with a specific aclacinomycin-negative mutant.
Yoshimoto
A
A
Central Research Laboratories, Mercian Corporation, Kanagawa, Japan.
Johdo
O
O
Watanabe
Y
Y
Nishida
H
H
Okamoto
R
R
Takeuchi
T
T
D000818:Animals; D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis* / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D009154:Mutation; D013302:Streptomyces / Q000378:metabolism
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; C076090:betaclamycin B